omega-n-methylarginine has been researched along with simvastatin in 4 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (simvastatin) | Trials (simvastatin) | Recent Studies (post-2010) (simvastatin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 8,442 | 1,730 | 3,630 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | simvastatin (IC50) |
|---|---|---|---|
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | 1.164 | |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 4.426 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.7843 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 9.5 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0034 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0034 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0111 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 0.049 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bruin, TW; Koomans, HA; Rabelink, TJ; Stroes, ES | 1 |
| Green, D; O'Driscoll, G; Taylor, RR | 1 |
| Fujita, H; Morita, I; Murota, S; Nagao, M; Sano, M; Sato-Suzuki, I | 1 |
| Boegehold, MA; Nurkiewicz, TR | 1 |
1 trial(s) available for omega-n-methylarginine and simvastatin
| Article | Year |
|---|---|
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.
Topics: Acetylcholine; Anticholesteremic Agents; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nitroprusside; omega-N-Methylarginine; Placebos; Plethysmography; Regional Blood Flow; Simvastatin; Time Factors; Vasodilator Agents | 1997 |
3 other study(ies) available for omega-n-methylarginine and simvastatin
| Article | Year |
|---|---|
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.
Topics: Adult; Arginine; Blood Pressure; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forearm; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Infusions, Intravenous; Lovastatin; Male; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Serotonin; Simvastatin; Vasodilation | 1995 |
NO is not involved in the simvastatin induced cell division and differentiation in PC12 cells.
Topics: Animals; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermediate Filament Proteins; Membrane Glycoproteins; Nerve Tissue Proteins; Neurites; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; PC12 Cells; Peripherins; Rats; Simvastatin | 1998 |
Calcium-independent release of endothelial nitric oxide in the arteriolar network: onset during rapid juvenile growth.
Topics: Animals; Arterioles; Blood Pressure; Calcimycin; Calcium Signaling; Endothelium, Vascular; Enzyme Inhibitors; Ionophores; Male; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Simvastatin; Stress, Mechanical; Vascular Endothelial Growth Factor A; Vasodilation | 2004 |